ATE157401T1 - Monoklonale antikörper gegen humanes ige - Google Patents

Monoklonale antikörper gegen humanes ige

Info

Publication number
ATE157401T1
ATE157401T1 AT92121934T AT92121934T ATE157401T1 AT E157401 T1 ATE157401 T1 AT E157401T1 AT 92121934 T AT92121934 T AT 92121934T AT 92121934 T AT92121934 T AT 92121934T AT E157401 T1 ATE157401 T1 AT E157401T1
Authority
AT
Austria
Prior art keywords
cir
ige
monoclonal antibodies
human
bind
Prior art date
Application number
AT92121934T
Other languages
English (en)
Inventor
Naohiro Washida
Toshiko Yoshida
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of ATE157401T1 publication Critical patent/ATE157401T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92121934T 1991-12-24 1992-12-23 Monoklonale antikörper gegen humanes ige ATE157401T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP35700591A JP3156237B2 (ja) 1991-12-24 1991-12-24 抗ヒトＩｇＥ モノクローナル抗体

Publications (1)

Publication Number Publication Date
ATE157401T1 true ATE157401T1 (de) 1997-09-15

Family

ID=18451888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92121934T ATE157401T1 (de) 1991-12-24 1992-12-23 Monoklonale antikörper gegen humanes ige

Country Status (10)

Country Link
US (1) US5625039A (de)
EP (1) EP0550020B1 (de)
JP (1) JP3156237B2 (de)
KR (1) KR930012827A (de)
AT (1) ATE157401T1 (de)
CA (1) CA2086131C (de)
DE (1) DE69221845T2 (de)
DK (1) DK0550020T3 (de)
ES (1) ES2106815T3 (de)
ZA (1) ZA9210006B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020859A1 (en) * 1995-12-08 1997-06-12 Idexx Laboratories, Inc. Methods and compositions concerning allergy in dogs
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
ZA971607B (en) * 1996-03-12 1998-08-25 Univ Johns Hopkins Methods of treatment of allergic diseases
US6060326A (en) * 1997-04-07 2000-05-09 Heska Corporation Method to detect canine IgE and kit therefor
AU743647B2 (en) * 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
WO2000072879A1 (en) * 1999-05-26 2000-12-07 Tanox, Inc. TREATING ALLERGIC DISEASES WITH IMMUNOTHERAPY AND IgE ANTAGONISTS
AU6904100A (en) * 1999-08-24 2001-03-19 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene
HK1048127A1 (en) * 2000-01-14 2003-03-21 Daiichi Pharmaceutical Co., Ltd. Novel peptide and screening method by using the same
AU1951001A (en) * 2000-04-06 2001-09-17 Panacea Pharm Llc Microbial delivery system
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US6787524B2 (en) 2000-09-22 2004-09-07 Tanox, Inc. CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies
SE0101093D0 (sv) * 2001-03-28 2001-03-28 Pharmacia Diagnostics Ab Novel compound for treatment of allergy and asthma
EP2427497B1 (de) 2009-05-07 2016-12-07 Stallergenes Verwendung von igg1-immunoglobulinen und/oder liganden des cd32-rezeptors zur behandlung entzündlicher krankheiten und ereignisse über die schleimhaut

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
US4714759A (en) * 1985-12-02 1987-12-22 Whitaker Jr Robert B Immunotoxin therapy of allergy
US4940782A (en) * 1987-06-08 1990-07-10 G. D. Searle & Co. Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore
JP2735196B2 (ja) * 1987-10-14 1998-04-02 イムネット アレルギーの免疫毒素治療
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
AU618317B2 (en) * 1987-12-31 1991-12-19 Tanox Biosystems, Inc. Unique antigenic epitopes on ige-bearing b lymphocytes
GB8910263D0 (en) * 1989-05-04 1989-06-21 Ciba Geigy Ag Monoclonal antibodies specific for an immunoglobulin isotype
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment

Also Published As

Publication number Publication date
DE69221845D1 (de) 1997-10-02
CA2086131C (en) 2003-05-13
ES2106815T3 (es) 1997-11-16
JP3156237B2 (ja) 2001-04-16
EP0550020B1 (de) 1997-08-27
US5625039A (en) 1997-04-29
JPH05199895A (ja) 1993-08-10
KR930012827A (ko) 1993-07-21
DE69221845T2 (de) 1998-04-09
ZA9210006B (en) 1993-06-29
EP0550020A2 (de) 1993-07-07
EP0550020A3 (en) 1994-08-24
DK0550020T3 (da) 1997-09-29
CA2086131A1 (en) 1993-06-25

Similar Documents

Publication Publication Date Title
ATE157401T1 (de) Monoklonale antikörper gegen humanes ige
NO346167B1 (no) Humanisert, glykoomkonstruert Type II anti-CD20 antistoff og anvendelse derav, samt vertscelle og farmasøytisk sammensetning
DK0502812T3 (da) Rekombinante antistoffer, som er specifikke for en vækstfaktorreceptor
DE69309472D1 (de) Fusionsproteine von monomeren und dimeren von antikörperfragmenten
DE60032486D1 (de) Prion protein peptide und deren verwendung
DE122006000006I2 (de) Veränderte Immunglobuline für spezifische FC-Epsilon Rezeptoren
DE69429723D1 (de) Stressproteine und ihre verwendung
FI973120A0 (fi) Ihmisen gp39:n eri epitoopeille spesifisiä monoklonaalisia vasta-aineita ja menetelmiä niiden käyttämiseksi diagnosoinnissa ja terapiassa
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
DE69032979D1 (de) Bispezifische heteroantikörper mit zweifachen effektorfunktionen
CY1109093T1 (el) Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι
ATE122394T1 (de) Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung.
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
ATE314087T1 (de) Impfstoffe mit erhöhter wirkung basierend auf chimären immunoglobulin e peptiden
ATE248189T1 (de) Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung
DE69115917D1 (de) Humane gammainterferonantagonisten
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
BG99074A (bg) Рекомбинантни човешки нiv-неутрализиращи моноклонални антитела за профилактика и лечение на нiv инфекция
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
DE69115104D1 (de) Composition comprising at least two different antibodies or fragments thereof.
DE69840628D1 (de) Nicht-anaphylaktische allergenarten und ihre verwendung
PT524421E (pt) Herpesvirus humano tipo 6 proteina p 100, sequencias de adn correspondentes, preparacao e utilizacao
ATE205255T1 (de) Spezifische antikörper gegen aktivierte plättchen,ihre herstellung und ihre verwendung in diagnose und therapie
Hu et al. Identification of superantigen TSST-1 sequence important for induction of T cell proliferation using synthetic peptides and antibody to CD28

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee